Beuth / Moss Complementary Oncology

Adjunctive Methods in the Treatment of Cancer
1. Auflage 2005
ISBN: 978-3-13-257954-5
Verlag: Thieme
Format: EPUB
Kopierschutz: 6 - ePub Watermark

E-Book, Englisch, 312 Seiten, ePub

One of every four deaths occurring in the United States today is due to cancer, and the number of diagnoses continues to increase. Fortunately, however, cancer treatments are improving, which means more and more patients are surviving for longer periods. Complementary methods have played an important role in these treatments, showing benefits such as a higher quality of life, reduced instance and severity of the side effects of standard therapy, and a general improvement of the patient's immunological state. Indeed, these methods - from carefully monitored nutrition, exercise, and psychological support to enzyme substitution, phytotherapy, hyperthermia and microbiology therapy - are critical to a treatment's overall success. More than ever, doctors need accurate, up-to-date information about which methods have been proven in scientifically based clinical studies (EBM) to be acceptable for use in conjunction with standard treatment methods. In this unique book, experts ranging across medical disciplines present data on the efficacy of these methods as they are currently being used, the necessary scientific background, and practical advice for introducing them into practice. With illustrations, tables, and detailed descriptions, this book is an ideal reference and an invaluable tool for educating patients about this encouraging aspect of cancer therapy. Throughout, the contributors emphasize the latest scientifically and clinically tested treatments. A useful chart lays out in detail which treatments are applicable for various types of cancers and what effects they have been shown to cause. The word is out about the beneficial qualities of complementary therapies in the treatment of cancer. More physicians are offering it to their patients, and more and more patients are demanding it. You - and your patients - cannot afford to be without this valuable resource.

Josef Beuth, Ralph W. Moss

Zielgruppe

Ärzte

Autoren/Hrsg.

Beuth, Josef

Moss, Ralph W.

Fachgebiete

• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Onkologie, Krebsforschung
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Komplementäre Medizin, Asiatische Medizin (TCM), Heilpraktiker

Inhaltsverzeichnis

1 Introduction to Complementary Medicine in Oncology
2 The Conventional Treatment of Cancer: The Case of Non-Small Cell Lung Cancer
3 Tumor Immunology
4 Introduction to Medical Biometry
5 Expert Systems in Complementary Oncology
6 Observational Studies on Drugs Efficacy
7 Electronically Supported Outcome Measurement
8 Cancer and Nutrition
9 Exercise in Cancer Prevention and Follow-up
10 Psycho-oncology
11 Biological Basis for Using High Dose Multiple Antioxidants as an Adjunct to Radiotherapy, Chemotherapy, and Experimental Cancer Therapies
12 Selenium in Oncology
13 Proteolytic Enzymes
14 Lectin-Standardized Mistletoe Extracts
15 Mistletoe Extracts from the Anthroposophical Point of View
16 Thymic Peptides
17 Probiotic Therapy
18 Blockade of Adhesion Molecules
19 Tumor Vaccination and Antibody-Mediated Immuno-therapy
20 Hyperthermia
21 Applied Complementary Oncology
22 Advances in Oncology—From Research to Application

Leseproben

List of Abbreviations

a-TS            a-tocopherol succinate

ADCC             antibody-dependent cellular cytotoxicity

AJCC              American Joint Committee on Cancer

APC                antigen-presenting cell

ASCO              American Society of Clinical Oncology

ASI                  active specific immunotherapy (for cancer)

ATBC              a-tocopherol plus ß-carotene

ATRA              all-transretinoic acid

ATV                 autologous tumor vaccine

AVI                  autovaccine for intestinal tract

AWB               Anwendungsbeobachtungen (specific observational studies; a German variant of postmarketing surveillance studies)

BALT              bronchus-associated lymphoid tissue

BCG                bacillus of Calmette-Guerrin

BfArM            Federal Institute for Drugs and Medical Devices

BSC                best supportive care

CALGB          Cancer and Leukemia Group B

CAM               complementary and alternative medicine

CAP                catabolite activation protein

CARET           ß-Carotene and Retinol Efficacy Trial

CDC                complement-dependent cytotoxicity

CHART           continuous hyperfractionated accelerated radiotherapy

CMF                cyclophosphamide, methotrexate, fluorouracil (chemotherapy)

CML               chronic myeloid leukemia

CR                  complete remission

CRF                case report forms

CTL                cytotoxic lymphocyte

DACH            German, Austrian, and Swiss Societies of Nutrition

DC                  dendritic cells

DGE               German Society of Nutrition

DHA               dehydroascorbic acid

DHT               deep hyperthermia

DNA              deoxyribonucleic acid

DRI                dietary reference intake

DTH               delayed-type hypersensitivity

DTIC              5-(3,3-dimethyl-1-triazeno)-imidazol-4-carboximide (dacarbazine)

EBM              evidence-based medicine

EBV               Epstein–Barr virus

ECOG            Eastern Collaborative Oncology Group

EGCG            epigallocatechin gallate

EGF               epidermal growth factor

EGFR             epidermal growth factor receptor

EMEA            European Agency for the Evaluation of Medicinal Products

FDA                Food and Drug Administration

FGF                fibroblast growth factor

FKJ                fine-needle catheter jejunostomy

GAC              germ-free animal characteristics

Gal                 galactose

GalNAc         N-acetyl-D-galactosamine

GCP              good clinical practices (placebo controlled, prospective randomized, double-blind multicenter study)

GEP              good epidemiological practices

GM-CSF       granulocyte–macrophage colonystimulating factor

GSH-Px        glutathione peroxidase

HAA             heterocyclic aromatic amines

HADS           Hospital Anxiety and Depression Scale

HAMA          human antimouse antibody

HBP              hepatic binding protein

HL                hepatic lectin

HLA             human lymphocyte antigen

HRQOL        health-related quality of life

HSP              heat shock protein

ICH              International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use

ICHP            intracavitary hyperthermic perfusion (perfusion hyperthermia)

IHT              interstitial hyperthermia

IL                 interleukin

IMS              Institute for Medical Statistics

iNO              inducible nitric oxide synthetase

IOM             Institute of Medicine

IPHP            intraperitoneal hyperthermic perfusion

IplHP            intrapleural hyperthermic perfusion

IRA               infrared-A radiation

IRB               Institutional Review Board

ISGNAS        International Study Group of New Antimicrobial Strategies

ITT                intention-to-treat analysis

IVHP             intravesicular hyperthermic perfusion

JNCI              Journal of the National Cancer Institute

LAK               lymphokine-activated killer cell

LCL               lymphoblastoid cell line

LHT               local hyperthermia

LPS                lipopolysaccharide

MAC             microflora-associated characteristics

Mab               monoclonal antibody

MALT           mucosa-associated lymphoid tissue

MCP-1           monocyte chemotactic protein 1

MFH              magnetic fluid...

Über Autor(innen)

Josef Beuth, Ralph W. Moss